Next Steps for Research Investigating Adverse Effects With Rosuvastatin Use
Jung-Im Shin, MD, PhD, assistant professor at Johns Hopkins University Bloomberg School of Public Health, discusses next steps in potential future research avenues following the results of her analysis into the risk of hematuria and proteinuria associated with rosuvastatin use.
Pharmacy Times interviewed Jung-Im Shin, MD, PhD, assistant professor at Johns Hopkins University Bloomberg School of Public Health, on her presentation at the American Society of Nephrology’s Kidney Week 2021 on the association of rosuvastatin use with the risk of hematuria and proteinuria.
During the interview, Shin discussed what the next steps are in terms of potential future research avenues following the results of her analysis into the risk of hematuria and proteinuria associated with rosuvastatin use.
